173 related articles for article (PubMed ID: 35137040)
1. Serum N-glycomics of a novel CDG-IIb patient reveals aberrant IgG glycosylation.
Beimdiek J; Hennig R; Burock R; Puk O; Biskup S; Rapp E; Lesinski-Schiedat A; Buettner FFR; Das AM
Glycobiology; 2022 Apr; 32(5):380-390. PubMed ID: 35137040
[TBL] [Abstract][Full Text] [Related]
2. Glycomic Characterization of Induced Pluripotent Stem Cells Derived from a Patient Suffering from Phosphomannomutase 2 Congenital Disorder of Glycosylation (PMM2-CDG).
Thiesler CT; Cajic S; Hoffmann D; Thiel C; van Diepen L; Hennig R; Sgodda M; Weiβmann R; Reichl U; Steinemann D; Diekmann U; Huber NM; Oberbeck A; Cantz T; Kuss AW; Körner C; Schambach A; Rapp E; Buettner FF
Mol Cell Proteomics; 2016 Apr; 15(4):1435-52. PubMed ID: 26785728
[TBL] [Abstract][Full Text] [Related]
3. Glycosylation, hypogammaglobulinemia, and resistance to viral infections.
Sadat MA; Moir S; Chun TW; Lusso P; Kaplan G; Wolfe L; Memoli MJ; He M; Vega H; Kim LJY; Huang Y; Hussein N; Nievas E; Mitchell R; Garofalo M; Louie A; Ireland DC; Grunes C; Cimbro R; Patel V; Holzapfel G; Salahuddin D; Bristol T; Adams D; Marciano BE; Hegde M; Li Y; Calvo KR; Stoddard J; Justement JS; Jacques J; Priel DAL; Murray D; Sun P; Kuhns DB; Boerkoel CF; Chiorini JA; Di Pasquale G; Verthelyi D; Rosenzweig SD
N Engl J Med; 2014 Apr; 370(17):1615-1625. PubMed ID: 24716661
[TBL] [Abstract][Full Text] [Related]
4. Synergistic use of glycomics and single-molecule molecular inversion probes for identification of congenital disorders of glycosylation type-1.
Abu Bakar N; Ashikov A; Brum JM; Smeets R; Kersten M; Huijben K; Keng WT; Speck-Martins CE; de Carvalho DR; de Rizzo IMPO; de Mello WD; Heiner-Fokkema R; Gorman K; Grunewald S; Michelakakis H; Moraitou M; Martinelli D; van Scherpenzeel M; Janssen M; de Boer L; van den Heuvel LP; Thiel C; Lefeber DJ
J Inherit Metab Dis; 2022 Jul; 45(4):769-781. PubMed ID: 35279850
[TBL] [Abstract][Full Text] [Related]
5. MOGS-CDG: Quantitative analysis of the diagnostic Glc
Post MA; de Wit I; Zijlstra FSM; Engelke UFH; van Rooij A; Christodoulou J; Tan TY; Le Fevre A; Jin D; Yaplito-Lee J; Lee BH; Low KJ; Mallick AA; Õunap K; Pitt J; Reardon W; Vals MA; Wortmann SB; Wessels HJCT; Bärenfänger M; van Karnebeek CDM; Lefeber DJ
J Inherit Metab Dis; 2023 Mar; 46(2):313-325. PubMed ID: 36651519
[TBL] [Abstract][Full Text] [Related]
6. Congenital disorders of glycosylation type IIb with MOGS mutations cause early infantile epileptic encephalopathy, dysmorphic features, and hepatic dysfunction.
Anzai R; Tsuji M; Yamashita S; Wada Y; Okamoto N; Saitsu H; Matsumoto N; Goto T
Brain Dev; 2021 Mar; 43(3):402-410. PubMed ID: 33261925
[TBL] [Abstract][Full Text] [Related]
7. ALG12-CDG: novel glycophenotype insights endorse the molecular defect.
Sturiale L; Bianca S; Garozzo D; Terracciano A; Agolini E; Messina A; Palmigiano A; Esposito F; Barone C; Novelli A; Fiumara A; Jaeken J; Barone R
Glycoconj J; 2019 Dec; 36(6):461-472. PubMed ID: 31529350
[TBL] [Abstract][Full Text] [Related]
8. Updated clinical and glycomic features of mannosyl-oligosaccharide glucosidase deficiency: Two case reports.
Abuduxikuer K; Wang L; Zou L; Cao CY; Yu L; Guo HM; Liang XM; Wang JS; Chen L
World J Clin Cases; 2022 Jul; 10(21):7397-7408. PubMed ID: 36158009
[TBL] [Abstract][Full Text] [Related]
9. Abrogation of glucosidase I-mediated glycoprotein deglucosylation results in a sick phenotype in fission yeasts: Model for the human MOGS-CDG disorder.
Gallo GL; Valko A; Aramburu SI; Etchegaray E; Völker C; Parodi AJ; D'Alessio C
J Biol Chem; 2018 Dec; 293(52):19957-19973. PubMed ID: 30389790
[TBL] [Abstract][Full Text] [Related]
10. N-Glycosylation of Serum IgG and Total Glycoproteins in MAN1B1 Deficiency.
Saldova R; Stöckmann H; O'Flaherty R; Lefeber DJ; Jaeken J; Rudd PM
J Proteome Res; 2015 Oct; 14(10):4402-12. PubMed ID: 26401844
[TBL] [Abstract][Full Text] [Related]
11. Clinical, molecular and glycophenotype insights in SLC39A8-CDG.
Bonaventura E; Barone R; Sturiale L; Pasquariello R; Alessandrì MG; Pinto AM; Renieri A; Panteghini C; Garavaglia B; Cioni G; Battini R
Orphanet J Rare Dis; 2021 Jul; 16(1):307. PubMed ID: 34246313
[TBL] [Abstract][Full Text] [Related]
12. Mass spectrometry glycophenotype characterization of ALG2-CDG in Argentinean patients with a new genetic variant in homozygosis.
Papazoglu GM; Cubilla M; Pereyra M; de Kremer RD; Pérez B; Sturiale L; Asteggiano CG
Glycoconj J; 2021 Apr; 38(2):191-200. PubMed ID: 33644825
[TBL] [Abstract][Full Text] [Related]
13. Characteristic dysmorphic features in congenital disorders of glycosylation type IIb.
Kim YM; Seo GH; Jung E; Jang JH; Kim SZ; Lee BH
J Hum Genet; 2018 Mar; 63(3):383-386. PubMed ID: 29235540
[TBL] [Abstract][Full Text] [Related]
14. Processing of N-linked carbohydrate chains in a patient with glucosidase I deficiency (CDG type IIb).
Völker C; De Praeter CM; Hardt B; Breuer W; Kalz-Füller B; Van Coster RN; Bause E
Glycobiology; 2002 Aug; 12(8):473-83. PubMed ID: 12145188
[TBL] [Abstract][Full Text] [Related]
15. Early onset epileptic and developmental encephalopathy and MOGS variants: a new diagnosis in the whole exome sequencing (WES) ERA : Report of a new patient and review of the literature.
Teutonico F; Volpe C; Proto A; Costi I; Cavallari U; Doneda P; Iascone M; Sturiale L; Barone R; Martinelli S; Vignoli A
Neurogenetics; 2024 Mar; ():. PubMed ID: 38498292
[TBL] [Abstract][Full Text] [Related]
16. Clinical glycomics for the diagnosis of congenital disorders of glycosylation.
Abu Bakar N; Lefeber DJ; van Scherpenzeel M
J Inherit Metab Dis; 2018 May; 41(3):499-513. PubMed ID: 29497882
[TBL] [Abstract][Full Text] [Related]
17. Modeling human congenital disorder of glycosylation type IIa in the mouse: conservation of asparagine-linked glycan-dependent functions in mammalian physiology and insights into disease pathogenesis.
Wang Y; Tan J; Sutton-Smith M; Ditto D; Panico M; Campbell RM; Varki NM; Long JM; Jaeken J; Levinson SR; Wynshaw-Boris A; Morris HR; Le D; Dell A; Schachter H; Marth JD
Glycobiology; 2001 Dec; 11(12):1051-70. PubMed ID: 11805078
[TBL] [Abstract][Full Text] [Related]
18. Compound heterozygous variants in MOGS inducing congenital disorders of glycosylation (CDG) IIb.
Li M; Xu Y; Wang Y; Yang XA; Jin D
J Hum Genet; 2019 Mar; 64(3):265-268. PubMed ID: 30587846
[TBL] [Abstract][Full Text] [Related]
19. Use of Endoglycosidase H as a diagnostic tool for MAN1B1-CDG patients.
Duvet S; Mouajjah D; Péanne R; Matthijs G; Raymond K; Jaeken J; Morava E; Foulquier F
Electrophoresis; 2018 Dec; 39(24):3133-3141. PubMed ID: 29947113
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of α-glucosidase I alters glycoprotein glycosylation and lifespan in Caenorhabditis elegans.
Katoh T; Takase J; Tani Y; Amamoto R; Aoshima N; Tiemeyer M; Yamamoto K; Ashida H
Glycobiology; 2013 Oct; 23(10):1142-51. PubMed ID: 23836288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
